-
10007133-10Furan fatty acids are unique, naturally occurring lipids that are found in significant amounts in dietary phospholipids, such as in salmon roe. CMPF is an endogenous metabolite of furan fatty acids in humans.
-
10007133-5Furan fatty acids are unique, naturally occurring lipids that are found in significant amounts in dietary phospholipids, such as in salmon roe. CMPF is an endogenous metabolite of furan fatty acids in humans.
-
10007133-500Furan fatty acids are unique, naturally occurring lipids that are found in significant amounts in dietary phospholipids, such as in salmon roe. CMPF is an endogenous metabolite of furan fatty acids in humans.
-
9001871-1An internal standard for the quantification of CMPF by GC- or LC-MS.
-
9001871-10An internal standard for the quantification of CMPF by GC- or LC-MS.
-
9001871-5An internal standard for the quantification of CMPF by GC- or LC-MS.
-
9001871-500An internal standard for the quantification of CMPF by GC- or LC-MS.
-
14618-10A competitive, non-NMDA glutamate receptor antagonist (IC<sub>50</sub>s = 0.3 and 1.5 &muM for AMPA and kainate receptors, respectively, versus IC<sub>50</sub> = 25 &muM for NMDA receptors).
-
14618-25A competitive, non-NMDA glutamate receptor antagonist (IC<sub>50</sub>s = 0.3 and 1.5 &muM for AMPA and kainate receptors, respectively, versus IC<sub>50</sub> = 25 &muM for NMDA receptors).
-
14618-5A competitive, non-NMDA glutamate receptor antagonist (IC<sub>50</sub>s = 0.3 and 1.5 &muM for AMPA and kainate receptors, respectively, versus IC<sub>50</sub> = 25 &muM for NMDA receptors).
-
14618-50A competitive, non-NMDA glutamate receptor antagonist (IC<sub>50</sub>s = 0.3 and 1.5 &muM for AMPA and kainate receptors, respectively, versus IC<sub>50</sub> = 25 &muM for NMDA receptors).
-
16244-1An irreversible inhibitor of mutant forms of EGFR including T790M (Ki = 21.5 nM) with minimal activity at the wild-type EGFR (Ki = 303.